Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or

Yuichi Ninomiya1, Shuichi Hamasaki, Keishi Saihara

  • 1Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima, Kagoshima, Japan.

Heart and Vessels
|April 5, 2008
PubMed

Insights

Long-term use of long-acting nitrates may negatively impact coronary endothelial function more than calcium channel antagonists in patients with mild coronary artery disease. This suggests calcium channel antagonists may offer better vascular health outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Biology

Background:

  • The long-term antianginal efficacy of long-acting nitrates versus calcium channel antagonists is not well-established.
  • Understanding effects on coronary endothelial function and vasoconstriction is crucial for patient management.

Purpose of the Study:

  • To compare coronary endothelial cell function and coronary artery vasoconstriction.
  • To evaluate patients with normal or mildly diseased arteries on long-term nitrates or calcium channel antagonists.

Main Methods:

  • Doppler flow study of the left anterior descending coronary artery in 42 patients.
  • Intracoronary administration of papaverine, acetylcholine (Ach), and nitroglycerin.
  • Assessment of vascular reactivity and vasoconstrictive response to Ach.

Main Results:

  • Acetylcholine-induced coronary blood flow and diameter increase was significantly smaller in the nitrates group.
  • The constrictive response to acetylcholine was significantly greater in the nitrates group.
  • Long-term nitrates showed less favorable effects on endothelial function compared to calcium channel antagonists.

Conclusions:

  • Long-acting nitrates may have less favorable effects on coronary endothelial function and vasoconstriction.
  • Calcium channel antagonists may offer superior vascular benefits in patients with normal or mildly diseased coronary arteries.
  • Further research is needed to confirm long-term clinical outcomes.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...